• Nitrocefin for Validating β-Lactamase Inhibitors

  2026-09-26

  Nitrocefin is a chromogenic cephalosporin substrate that can connect computational inhibitor discovery to functional β-lactamase testing. This article explains how to interpret its colorimetric signal, assess peptide-inhibitor candidates, and avoid confusing enzyme inhibition with bacterial susceptibility.

• Imipenem Workflows for Antibacterial Research

  2026-09-25

  Use Imipenem to connect broth-based antibacterial testing and immune-cell assays with a carefully controlled investigation of antimicrobial-releasing neural probe coatings. The study provides a spatial-proteomics framework—not evidence for imipenem-loaded probes—so the article separates established findings from practical, hypothesis-testing workflows.

• Cyclopamine: Applied Hedgehog Pathway Workflows

  2026-09-25

  Use Cyclopamine to test whether Smoothened-dependent Hedgehog signaling contributes to cancer-cell growth or developmental phenotypes. This guide turns its pathway selectivity and reported activity into practical dosing, readout, and troubleshooting strategies—while distinguishing direct Hedgehog evidence from the separate Alzheimer’s disease study used as a model for experimental rigor.

• MK-2206 Dihydrochloride: Practical Assay Guide

  2026-09-24

  Use MK-2206 dihydrochloride to test how Akt inhibition changes cancer-cell signaling and response to treatment, with matched pathway and apoptosis readouts. This guide pairs practical assay planning with a clear distinction between Akt-focused experiments and recent Wnt-driven bone-metabolism findings.

• Nitrocefin Assays for β-Lactamase Research

  2026-09-24

  Nitrocefin turns β-lactamase hydrolysis into a rapid yellow-to-red signal, making it useful for enzyme characterization, resistance-mechanism research, and early inhibitor screening. This guide translates GOB-38 research into practical assay choices while clarifying what a colorimetric readout can—and cannot—show.

• MHY1485 Workflows for mTOR and Autophagy Studies

  2026-09-24

  Use MHY1485 to probe mTOR activation, autophagosome–lysosome fusion, and ovarian follicle development in controlled research workflows. This guide pairs practical dose-and-time pilot designs with interpretation safeguards, including how to distinguish LC3-II accumulation from increased autophagic flux.

• Bradford Protein Assay Kit: Setup and QC

  2026-09-23

  The Bradford Protein Assay Kit (SKU K4103) provides a rapid colorimetric approach for measuring protein concentration in compatible solution samples. It is suitable for enzyme assays, purification fractions, and molecular biology workflows, but detergent-containing or compositionally atypical samples require compatibility testing and careful interpretation.

• Meropenem: PBP Mechanism and Research Workflows

  2026-09-22

  Meropenem is a β-lactam antibiotic carbapenem that inhibits penicillin-binding proteins and supports research on broad-spectrum antibacterial activity. Its documented handling profile, PBP biology, and preclinical infection-model findings make it useful for controlled in vitro and translational studies, but not as a substitute for clinical susceptibility-guided treatment.

• Mycobacterium tuberculosis WecA: Kinetic Study

  2026-09-22

  A 2026 study establishes a practical workflow for producing and analyzing the difficult-to-express Mycobacterium tuberculosis membrane enzyme WecA. By combining regulated expression in Escherichia coli Lemo21(DE3), affinity purification, mass-spectrometric identification, and UMP-based activity monitoring, the authors provide a foundation for mechanistic studies and inhibitor evaluation.

• MK-2206 Dihydrochloride: Assay Design by Mechanism

  2026-09-21

  MK-2206 dihydrochloride enables mechanism-led interrogation of Akt phosphorylation, apoptosis, and PI3K/Akt/mTOR signaling. This article translates evidence from a glucocorticoid-associated osteonecrosis study into better assay controls, readouts, and cross-domain research decisions.

• Patient-Derived Gastric Cancer Assembloids

  2026-09-21

  This study develops a patient-derived gastric cancer assembloid that combines matched tumor organoids with stromal subpopulations from the same tissue. The model reveals how tumor–stroma composition alters gene expression and drug sensitivity, creating a more informative platform for personalized cancer biology research and resistance studies.

• D-Lin-MC3-DMA for Reliable LNP Cell Assays

  2026-09-20

  This scenario-based guide explains how D-Lin-MC3-DMA (SKU A8791) can be incorporated into siRNA and mRNA lipid nanoparticle workflows while separating delivery effects from cytotoxicity. It covers formulation controls, solvent and storage decisions, assay interpretation, and practical vendor-selection criteria supported by product information and peer-reviewed evidence.

• EZ Cap™ Cas9 mRNA (m1Ψ) Workflow Guide

  2026-09-19

  Build more controlled CRISPR-Cas9 experiments with a transient, Cap1-capped Cas9 mRNA workflow designed for efficient translation and reduced innate immune signaling. This guide connects practical handling and dose optimization with the reference study’s nuclear-export strategy for improving editing precision.

• PDHA1 Acetylation, Cuproptosis, and Enzalutamide Resistance

  2026-09-19

  This study identifies PDHA1 acetylation signaling as a metabolic–epigenetic axis that suppresses cuproptosis and weakens enzalutamide activity in castration-resistant prostate cancer. Its findings connect acetyl-CoA production, H3K27ac, SLC7A11-driven glutathione synthesis, and copper handling, suggesting that PDHA1 targeting may help restore anti-androgen sensitivity in resistant disease.

• Mitoxantrone: Mechanism, Resistance & Research Use

  2026-09-18

  Mitoxantrone is a topoisomerase II inhibitor and anticancer research compound that damages DNA through intercalation and stabilization of the DNA–topoisomerase II complex. Mitozantrone is a spelling variant used in some searches; this article uses the standard name, Mitoxantrone, and explains ABCG2-mediated resistance, product handling, and assay integration.

8731 records 2/583 page Previous Next 12345 下5页 Last page